BRIEF-Bio-Rad Q4 Adjusted EPS USD 2.9 Vs. IBES Estimate USD 2.87

Reuters
14 Feb
BRIEF-Bio-Rad Q4 Adjusted EPS USD 2.9 Vs. IBES Estimate USD 2.87

Feb 13 (Reuters) - Bio-Rad Q4 EPS USD -25.57.

  • Q4 EBIT margin 8.7%
  • Q4 sales USD 667.5 million vs. IBES estimate USD 679.3 million
  • Q4 gross margin 51.2%
  • Q4 net income USD -715.8 million
  • outlook FY adjusted revenue growth 1.5-3.5%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10